Valneva Announces Lifting of European Medicines Agency's Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
1. EMA lifts vaccination restrictions for IXCHIQ® in people 65 and older. 2. Risks remain for those with underlying health conditions when using IXCHIQ®. 3. IXCHIQ® effectively generates antibodies against chikungunya, aiding older individuals. 4. Chikungunya cases exceed 3.7 million in the Americas over 10 years. 5. Global public health issues from chikungunya emphasized by WHO due to climate change.